Yimeng Xue
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
RNF213 Variants Associated With Periventricular Anastomosis Regression After Revascularization in Moyamoya Disease.
Journal: CNS neuroscience & therapeutics
Published: January 05, 2026
Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review.
Journal: Frontiers in oncology
Published: October 27, 2025
Unraveling the Dyslipidemic Landscape in Moyamoya Disease: OxLDL as a Key Biomarker.
Journal: CNS neuroscience & therapeutics
Published: February 10, 2025
Molecular Dynamics Simulation of Nanodroplets Impacting Stripe-Textured Surfaces.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: May 24, 2022
Association of RNF213 Variants With Periventricular Anastomosis in Moyamoya Disease.
Journal: Stroke
Published: May 11, 2022
Tumor Necrosis Factor-α: The Next Marker of Stroke.
Journal: Disease markers
Published: October 14, 2021
Application of Induced Pluripotent Stem Cells in Moyamoya Disease: Progress and Promises.
Journal: Current stem cell research & therapy
Published: August 11, 2021
Immune Checkpoints: Therapeutic Targets for Pituitary Tumors.
Journal: Disease markers
Published: June 14, 2021
Response to Letter to the Editor on "Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810 K Variant".
Journal: Journal of child neurology
Published: May 05, 2020
Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke.
Journal: Aging and disease
Published: March 14, 2020
N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway.
Journal: Journal of biomedical science
Published: March 02, 2020
Last Updated: 09/26/2026